BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 21704933)

  • 21. Use of intrathecal nicardipine for aneurysmal subarachnoid hemorrhage-induced cerebral vasospasm.
    Ehtisham A; Taylor S; Bayless L; Samuels OB; Klein MW; Janzen JM
    South Med J; 2009 Feb; 102(2):150-3. PubMed ID: 19139684
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Cerebral vasospasm after aneurysmal subarachnoid hemorrhage: an overview of pharmacologic management.
    Liu-Deryke X; Rhoney DH
    Pharmacotherapy; 2006 Feb; 26(2):182-203. PubMed ID: 16466324
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Bedside monitoring of cerebral blood flow in patients with subarachnoid hemorrhage.
    Hegner T; Krayenbühl N; Hefti M; Yonekawa Y; Keller E
    Acta Neurochir Suppl; 2001; 77():131-4. PubMed ID: 11563271
    [No Abstract]   [Full Text] [Related]  

  • 24. Value of triple H therapy in a patient with an ischemic penumbra following subarachnoid hemorrhage: a case study.
    Ogungbo B; Prakash S; Ushewokunze S; Etherson K; Sinar J
    J Neurosci Nurs; 2005 Dec; 37(6):326-8, 333. PubMed ID: 16396086
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Role of intraarterial therapy for cerebral vasospasm secondary to aneurysmal subarachnoid hemorrhage.
    Weant KA; Ramsey CN; Cook AM
    Pharmacotherapy; 2010 Apr; 30(4):405-17. PubMed ID: 20334460
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Hypertension may be the most important component of hyperdynamic therapy in cerebral vasospasm.
    Harrigan MR
    Crit Care; 2010; 14(3):151. PubMed ID: 20497601
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Two patients treated with intra-aortic balloon pump counterpulsation after subarachnoid hemorrhage].
    Sato K; Tokairin H; Kato M
    Masui; 2001 Aug; 50(8):859-62. PubMed ID: 11554017
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Caveats for triple-H therapy in the management of vasospasm after aneurysmal subarachnoid hemorrhage.
    Hunt MA; Bhardwaj A
    Crit Care Med; 2007 Aug; 35(8):1985-6. PubMed ID: 17667248
    [No Abstract]   [Full Text] [Related]  

  • 29. Does treatment modality affect vasospasm distribution in aneurysmal subarachnoid hemorrhage: differential use of intra-arterial interventions for cerebral vasospasm in surgical clipping and endovascular coiling populations.
    Cooke D; Seiler D; Hallam D; Kim L; Jarvik JG; Sekhar L; Ghodke B
    J Neurointerv Surg; 2010 Jun; 2(2):139-44. PubMed ID: 21990594
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Central hypervolemia with hemodilution impairs dynamic cerebral autoregulation.
    Ogawa Y; Iwasaki K; Aoki K; Shibata S; Kato J; Ogawa S
    Anesth Analg; 2007 Nov; 105(5):1389-96, table of contents. PubMed ID: 17959971
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Vasospasm probability index: a combination of transcranial doppler velocities, cerebral blood flow, and clinical risk factors to predict cerebral vasospasm after aneurysmal subarachnoid hemorrhage.
    Gonzalez NR; Boscardin WJ; Glenn T; Vinuela F; Martin NA
    J Neurosurg; 2007 Dec; 107(6):1101-12. PubMed ID: 18077946
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Hypertensive-hypervolemic therapy in cerebral vasospasm].
    Haberl RL; Villringer A
    Nervenarzt; 1990 Dec; 61(12):749-51. PubMed ID: 2079990
    [No Abstract]   [Full Text] [Related]  

  • 33. A multimodal concept in patients after severe aneurysmal subarachnoid hemorrhage: results of a controlled single centre prospective randomized multimodal phase I/II trial on cerebral vasospasm.
    Hänggi D; Eicker S; Beseoglu K; Behr J; Turowski B; Steiger HJ
    Cent Eur Neurosurg; 2009 May; 70(2):61-7. PubMed ID: 19711257
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The influence of cisternal and ventricular lavage on cerebral vasospasm in patients suffering from subarachnoid hemorrhage: analysis of effectiveness.
    Hänggi D; Steiger HJ
    Acta Neurochir Suppl; 2011; 110(Pt 2):95-8. PubMed ID: 21125452
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Does prophylactic postoperative hypervolemic therapy prevent cerebral vasospasm and improve clinical outcome after aneurysmal subarachnoid hemorrhage?
    Capampangan DJ; Wellik KE; Aguilar MI; Demaerschalk BM; Wingerchuk DM
    Neurologist; 2008 Nov; 14(6):395-8. PubMed ID: 19008746
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Hemodynamic management of subarachnoid hemorrhage.
    Treggiari MM;
    Neurocrit Care; 2011 Sep; 15(2):329-35. PubMed ID: 21786046
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Treatment of cerebral vasospasm after subarachnoid hemorrhage--a review.
    Wu CT; Wong CS; Yeh CC; Borel CO
    Acta Anaesthesiol Taiwan; 2004 Dec; 42(4):215-22. PubMed ID: 15679131
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Vasospasm treatment in intensive care].
    Bracco D; Chioléro R
    Rev Med Suisse Romande; 2000 Apr; 120(4):355-62. PubMed ID: 10859975
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Recommendations for the management of patients with aneurysmal subarachnoid hemorrhage].
    Raabe A; Beck J; Berkefeld J; Deinsberger W; Meixensberger J; Schmiedek P; Seifert V; Steinmetz H; Unterberg A; Vajkoczy P; Werner C;
    Zentralbl Neurochir; 2005 May; 66(2):79-91. PubMed ID: 15846536
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Intrathecal treatment of cerebral vasospasm.
    Zhang YP; Shields LB; Yao TL; Dashti SR; Shields CB
    J Stroke Cerebrovasc Dis; 2013 Nov; 22(8):1201-11. PubMed ID: 22651990
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.